Astrazeneca Pharma India Ltd Board of Directors
Board of Directors at Astrazeneca Pharma India Ltd
Executive Director
Non Executive Director
Chairman & Independent Directo
Non-Exec. & Independent Dir.
Managing Director
Key Highlights
- Shilpa Divekar Nirula joins the board as Chairman & Independent Directo, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Praveen Rao Akkinepally joins the board as Managing Director / Business Unit Head, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Bhavana Agrawal joins the board as Executive Director / Whole Time Director / CFO, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Revathy Ashok joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- MONICA WIDHANI joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Astrazeneca Pharma India Ltd
NSE: ASTRAZEN
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 29 Jul 2026 | 8179.35 |
| 28 Jul 2026 | 8069.5 |
| 27 Jul 2026 | 8167.9 |
| 24 Jul 2026 | 8000.1 |
| 23 Jul 2026 | 7873.6 |
| 22 Jul 2026 | 8033.05 |
| 21 Jul 2026 | 8090.2 |
| 20 Jul 2026 | 8063.6 |
| 17 Jul 2026 | 8025.95 |
| 16 Jul 2026 | 8092 |
Company Fundamentals for Astrazeneca Pharma India Ltd
Market Cap
20,448 Cr
EPS
76.5
P/E Ratio (TTM)
106.9
P/B Ratio (TTM)
23.4
Day’s High
8268.3
Day’s Low
8087.0
DTE
0.1
ROE
21.5
52 Week High
9850.0
52 Week Low
7630.0
ROCE
25.5
Market Price of Astrazeneca Pharma India Ltd
1M
1Y
3Y
5Y
Astrazeneca Pharma India Ltd News Hub
AstraZeneca slumps on recording dismal Q1 performance
Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter ended 30
Read more
08 Aug 24
Astrazeneca Pharma India reports standalone net loss of Rs 11.79 crore in the June 2024 quarter
Net loss of Astrazeneca Pharma India reported to Rs 11.79 crore in the quarter ended June 2024 as ag
Read more
08 Aug 24
Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions
Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed by IMFINZI
Read more
24 Sept 24
Astrazeneca Pharma India Ltd leads gainers in 'A' group
Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and National Alumini
Read more
24 Sept 24
